Reed's (NYSE American:REED) in our automated value investing analysis, with the cash flow history and price comparison below.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold Reed's to reach your target.
Hmm, we can't give any reliable projection for Reed's's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.
None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!
| Advantages | Disadvantages | Neutral |
|---|---|---|
| None. |
|
|
| REED Price (Reed's stock price per share) |
$1.47 | |
| PE Ratio versus Sector | 100% lower than other Unknown stocks | |
| PE Ratio versus Industry | 100% lower than other Unknown stocks | |
| Cash Yield | 1.16% | |
| Free Cash Flow Jitter | 69% |
No open-market insider buys or sells are recorded for the last 12 months.
Open-market buys and sells reported by Reed's's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2025-06-04 | Era Regenerative Medicine Ltd | Buy | 1,075,269 | -- |
| 2024-11-15 | Union Square Park Capital Management, LLC | Sell | 4,537 | $1.11 |
| 2024-11-14 | Union Square Park Capital Management, LLC | Sell | 5,988 | $1.13 |
| 2024-09-10 | Union Square Park Capital Management, LLC | Buy | 531,205 | $1.50 |
| 2024-04-29 | Snyder Norman E. Jr. (CEO) | Buy | 37,605 | -- |
| 2024-04-29 | Tinnelly Joann Christine (CFO) | Buy | 17,334 | -- |
| 2024-04-29 | Burleson Christopher Scott (CCO) | Buy | 5,209 | -- |
| 2023-12-06 | Bello John | Buy | 5,000 | $1.80 |
| 2023-11-28 | Bello John | Buy | 5,000 | $2.04 |
| 2023-05-25 | Union Square Park Capital Management, LLC | Buy | 193,424 | -- |
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 287,255 shares shorted. With 21,115,497 shares available for purchase and an average trading volume over the past 10 trading days of 82,780, it would take at least 3.5 days for all of the short holders to cover their shorts.
Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth
How to read this: free cash flow in plain terms, free cash flow jitter.
How to read this: what free cash flow is, why earnings matter.
Net income was negative in all 16 fiscal years from 2010 to 2025, so no ratio of operating cash flow to net income is shown. Operating cash flow totaled -$104 million over those years, against net income of -$150 million.
In 2025, net income was -$15.8 million and operating cash flow was -$17 million, so no ratio is shown for that year.
In 2014, capital expenditures were $0.3 million, 32.5% of operating cash flow of $1 million, which leaves an estimated $0.7 million after capex. Across the 3 years with reported capex, it averaged 42.5% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.
| Fiscal year | Net income (USD millions) | Operating cash flow (USD millions) | Capital expenditures (USD millions) | Operating cash flow / net income |
|---|---|---|---|---|
| 2010 | -1.3 | -0.8 | 0.4 | n/a |
| 2011 | -0.9 | -2.3 | 0.4 | n/a |
| 2012 | -0.5 | 1.2 | 0.5 | n/a |
| 2013 | -1.5 | 1.2 | 0.6 | n/a |
| 2014 | -0.8 | 1 | 0.3 | n/a |
| 2015 | -4 | -1.3 | 0.5 | n/a |
| 2016 | -5 | -2.5 | 0.4 | n/a |
| 2017 | -18.4 | -3.4 | 0.8 | n/a |
| 2018 | -10.3 | -9.3 | 0.2 | n/a |
| 2019 | -16.1 | -18.2 | 0.3 | n/a |
| 2020 | -10.2 | -9.5 | 0.1 | n/a |
| 2021 | -16.4 | -17.6 | 0.3 | n/a |
| 2022 | -20.1 | -15.5 | not reported | n/a |
| 2023 | -15.5 | -4.3 | 0.1 | n/a |
| 2024 | -13.2 | -6.1 | 0.2 | n/a |
| 2025 | -15.8 | -17 | 0.3 | n/a |
How to read this: why companies buy back shares, dividend yield explained.
Over the 3 fiscal years from 2021 to 2023 with dividend or share repurchase facts, estimated free cash flow totaled -$38.1 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.
| Fiscal year | Estimated free cash flow (USD millions) | Dividends paid (USD millions) | Cash spent repurchasing shares (USD millions) | Total returned (USD millions) | Total as a percent of estimated free cash flow |
|---|---|---|---|---|---|
| 2021 | -17.9 | n/a | 0 | 0 | n/a |
| 2022 | -15.7 | n/a | 0 | 0 | n/a |
| 2023 | -4.4 | n/a | 0 | 0 | n/a |
Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.
How to read this: earnings and margins.
Revenue was $20.4 million in 2010 and $34.1 million in 2025, a compound annual growth rate of 3.5% over 15 years.
Revenue fell 10.2% from 2024 to 2025.
Our estimated free cash flow was -$17.2 million in 2025, a negative margin of 50.5% of revenue, meaning the estimate was below zero. In 2010 the estimated margin was negative 5.9%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.
| Fiscal year | Revenue (USD millions) | Estimated free cash flow (USD millions) | Estimated free cash flow / revenue |
|---|---|---|---|
| 2010 | 20.4 | -1.2 | -5.9% |
| 2011 | 25 | -2.6 | -10.5% |
| 2012 | 30 | 0.8 | 2.5% |
| 2013 | 37.3 | 0.7 | 2.0% |
| 2014 | 43.4 | 0.6 | 1.3% |
| 2015 | 45.9 | -1.8 | -3.9% |
| 2016 | 42.5 | -3 | -7.1% |
| 2017 | 37.7 | -4 | -10.5% |
| 2018 | 38.1 | -9.7 | -25.5% |
| 2019 | 33.8 | -18.6 | -55.0% |
| 2020 | 41.6 | -9.9 | -23.7% |
| 2021 | 49.6 | -17.9 | -36.2% |
| 2022 | 53 | -15.7 | -29.6% |
| 2023 | 44.7 | -4.4 | -9.9% |
| 2024 | 38 | -6.3 | -16.5% |
| 2025 | 34.1 | -17.2 | -50.5% |
How to read this: how debt and assets are compared, the current ratio.
In 2011, cash and equivalents were $0.7 million against total liabilities of $9.1 million, or 7.9% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.
Total liabilities were 60.8% of total assets in 2025, compared with 65.1% in 2010, a decrease of 4.3 percentage points.
Stockholders equity was $9.2 million in 2025, compared with $4.1 million in 2010, a rise of 120.9%.
Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was -172.8% in 2025. Invested capital here is total assets less cash and current liabilities.
| Fiscal year | Total assets (USD millions) | Cash and equivalents (USD millions) | Total liabilities (USD millions) | Stockholders equity (USD millions) |
|---|---|---|---|---|
| 2010 | 11.9 | 1.1 | 7.7 | 4.1 |
| 2011 | 13.4 | 0.7 | 9.1 | 4.3 |
| 2012 | 13.8 | n/a | 9.7 | 4.1 |
| 2013 | 14.7 | n/a | 11.4 | 3.4 |
| 2014 | 17.1 | n/a | 13.4 | 3.7 |
| 2015 | 19.9 | n/a | 19.1 | 0.8 |
| 2016 | 18.9 | n/a | 20.5 | -1.7 |
| 2017 | 24.5 | n/a | 24 | 0.5 |
| 2018 | 12.5 | n/a | 19.2 | -6.7 |
| 2019 | 16 | n/a | 14.8 | 1.1 |
| 2020 | 20.1 | n/a | 9.7 | 10.4 |
| 2021 | 26.3 | n/a | 22.1 | 4.2 |
| 2022 | 25.5 | n/a | 34 | -8.5 |
| 2023 | 18.9 | n/a | 38.1 | -19.2 |
| 2024 | 25.1 | n/a | 18.5 | 6.6 |
| 2025 | 23.3 | n/a | 14.2 | 9.2 |
Reed's reported positive free cash flow in 3 of the 16 fiscal years we have from its current SEC filer.
Free cash flow is volatile from year to year, with a variability measure of 69%.
We do not estimate a fair value for Reed's while its free cash flow growth is not positive, so there is no value comparison here.
We do not have a dividend yield for Reed's.
Our value investing guide explains how to test these numbers against the filings themselves.
Every fiscal year on this page is reported by one SEC filer, CIK 1140215.
Each figure on this page comes from that filer.
How to read this: understanding investment risk.
Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.
Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.
The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.
This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.
Read the filings yourself: REED annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.
Advertisement supports free stock analysis content.
Does Reed's have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to REED: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.
Most Popular Articles
Gold-Silver Ratio Today: Chart and Average
What Happened to the Stock Market Today?
How to Make Money with Penny Stocks
When is the Right Time to Buy a Stock?
Always Choose Employer Matching 401k Contributions
What Does COVID-19 Mean for Stocks?
DCA vs Lump Sum: 155 Years of S&P 500 Historical Data